Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Precimed, a subsidiary of Greatbatch has successfully completed the acquisition of DePuy's Chaumont, France manufacturing facility. The Chaumont facility will continue to produce primary hip stems and shoulder implants for DePuy for the foreseeable future.
Subscribe to our email newsletter
This transaction, including a new four-year supply agreement with DePuy, enhances Greatbatch’s and Precimed’s strategic relationship with one of the largest orthopedic companies in the world. The addition of this facility will align Precimed closer to its orthopedic OEM customers and further extends its offerings to a full range of orthopedic implants notably for the hip, shoulder and knee segments.
The acquisition of the DePuy facility was structured as an asset purchase. The purchase price was funded with cash on hand and availability under Greatbatch’s revolving credit agreement.